Synchron Systems Enzymatic Creatinine (Cr-E) Reagent, Model A60298
Enzymatic Method, Creatinine. 510(k) K093458, from Beckman Coulter, Inc. (Brea, CA). Product code JFY, class 2.
As of Nov 19, 2026, K093458 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on Dec 4, 2009 after 28 days, with 1 recall tied to it in FDA's recall database.
- Review time: 28 days
- Recalls: 1
- Synchron Systems Enzymatic Creatinine (Cr-E) Reagent, Model A60298K091742 · Beckman Coulter, Inc. · Aug 14, 2009
| Started | Recall | Status |
|---|---|---|
| Apr 3, 2017 | Z-2080-2017Beckman Coulter has identified the following drugs as potential sources of interference: Metamizole (Dipyrone), Sulfasalazine, and Sulfapyridine and may result in false low results. | Terminated |
- Qscheck UisacrK252619 · Qstag, Inc. · Feb 20, 2026
- Atellica CH Enzymatic Creatinine_3 (ECre3)K212223 · Siemens Healthcare Diagnostics, Inc. · Nov 24, 2021
- Yumizen C1200 Creatinine PAPK193649 · Horiba Abx SAS · May 10, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Nov 6, 2009
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files